TheEdgeResearch
Home / Stocks / ALPAT.PA

Plant Advanced Technologies S.A. (ALPAT.PA)

PAR Healthcare Biotechnology
$4.48 ▲ +0.00%
Market Cap
$5.1M
Sector
Healthcare
Industry
Biotechnology
Beta
0.83
52-Wk Range
4.1-9.38
CEO
Jean-Paul Fèvre
Country
FR
Currency
EUR

Plant Advanced Technologies S.A. operates in the Biotechnology industry of the Healthcare sector, headquartered in Vandœuvre-lès-Nancy, GES, FR. The stock last traded at $4.48, up 0.00% on the session, giving a market capitalisation of $5.1M. Its beta of 0.83 implies it has historically moved less than the broad market.

Company profile
Exchange
Euronext Paris
Employees
11
IPO date
2011-09-27
Headquarters
Vandœuvre-lès-Nancy, GES, FR
About Plant Advanced Technologies S.A.

Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. Plant Advanced Technologies SA was incorporated in 2005 and is headquartered in Vandœuvre-lès-Nancy, France.

Comparable companies

Plant Advanced Technologies S.A. is most often compared with the following Healthcare names:

ALAMA.PAALBIO.PAALBLU.PAALEMG.PAALMKT.PAALNFL.PAALPRE.PAALTME.PAALVAL.PAMLLAB.PA
More research on ALPAT.PA
ALPAT.PA technical analysis ALPAT.PA TheEdge Score Compare against peers
Open full interactive analysis & DCF →